An extra 60 million doses of the Pfizer/BioNTech coronavirus jab have been secured by the UK Government for a booster vaccination programme in the autumn.
Officials are preparing a booster programme based on clinical need to ensure people have the strongest possible protection against the virus, according to the Department for Health and Social Care (DHSC).
This additional stock of the Pfizer/BioNTech jab – which has been rolled out in the UK since December – will be used alongside other approved vaccines for the booster programme.
England's Health Secretary Matt Hancock said: “Our vaccination programme is bringing back our freedom, but the biggest risk to that progress is the risk posed by a new variant.
“We’re working on our plans for booster shots, which are the best way to keep us safe and free while we get this disease under control across the whole world.
“These further 60 million doses will be used, alongside others, as part of our booster programme from later this year, so we can protect the progress that we’ve all made.”
The Government said it will publish further details on the booster programme in due course, with the policy informed by advice from the Joint Committee on Vaccination and Immunisation (JCVI).
It will also assess the results of clinical trials which have studied the use of different combinations of approved vaccines.
It comes as people aged 42 and over in England were called to come forward to get their vaccine, while one in four (25%) UK adults have had their second coronavirus jab.
